Related Experiment Video
Updated: Mar 16, 2026

09:02
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
8.0K
Collapsing glomerulopathy associated with hepatitis B infection: A case report
1Department of Pediatrics, Maulana Azad Medical College and Associated Hospitals, University of Delhi, New Delhi, India.
Indian Journal of Nephrology
|August 12, 2016
Summary
Collapsing glomerulopathy, a kidney disease variant, is linked to infections. This report details a rare pediatric case of collapsing glomerulopathy associated with hepatitis B infection.
Area of Science:
- Nephrology
- Pediatric Nephrology
- Infectious Diseases
Background:
- Collapsing glomerulopathy (CG) is a severe podocytopathy, often a variant of focal segmental glomerulosclerosis (FSGS).
- CG is recognized as a complication of various conditions including viral infections, autoimmune diseases, and certain drug toxicities.
- While CG is well-documented in human immunodeficiency virus (HIV) infection, its association with other viral hepatitis remains largely unreported.
Observation:
- A pediatric case presenting with clinical and histological features of collapsing glomerulopathy is described.
- The patient had a concurrent diagnosis of hepatitis B virus (HBV) infection.
- This presentation is unusual given the established links between CG and HIV, but not other hepatitis viruses.
Findings:
- The case highlights a potential, previously unconfirmed association between hepatitis B infection and the development of collapsing glomerulopathy in children.
- Histopathological examination confirmed the characteristic glomerular collapse and podocyte injury seen in CG.
- This finding expands the spectrum of infectious triggers implicated in CG pathogenesis.
Implications:
- This case suggests that hepatitis B infection should be considered in the differential diagnosis of collapsing glomerulopathy, particularly in pediatric populations.
- Further research is warranted to elucidate the mechanisms underlying HBV-associated CG and its potential frequency.
- Understanding this association may inform diagnostic and therapeutic strategies for children presenting with CG and concurrent HBV infection.
More Related Videos
Related Concept Videos
Nephrotic Syndrome I : Introduction
836
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
836
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
248
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248
Diseases of the Liver and Gallbladder
2.2K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
313
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
313

